{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:23Z","timestamp":1787020643487,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"PRIN 2022 project","award":["2022LTXXRP"],"award-info":[{"award-number":["2022LTXXRP"]}]},{"name":"Epi-MET","award":["0000019"],"award-info":[{"award-number":["0000019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07030-z","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:45:15Z","timestamp":1759491915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNA signatures of cancer risk in kidney transplant patients: insights from the COMETA study"],"prefix":"10.1186","volume":"23","author":[{"given":"Mariadelina","family":"Simeoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Grandinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-1254","authenticated-orcid":false,"given":"Alessia Maria","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Pollastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Calcutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Scrima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zappavigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Biancone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"4","key":"7030_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/jcm9041193","volume":"9","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Hansrivijit P, Leeaphorn N, Acharya P, Torres-Ortiz A, Kaewput W, et al. Recent advances and clinical outcomes of kidney transplantation. J Clin Med. 2020;9(4):1193.","journal-title":"J Clin Med"},{"issue":"1","key":"7030_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/0886022X.2016.1244077","volume":"39","author":"G D\u2019Onofrio","year":"2017","unstructured":"D\u2019Onofrio G, Simeoni M, Rizza P, Caroleo M, Capria M, Mazzitello G, Sacco T, et al. Quality of life, clinical outcome, personality and coping in chronic Hemodialysis patients. Ren Fail. 2017;39(1):45\u201353.","journal-title":"Ren Fail"},{"issue":"12","key":"7030_CR3","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1093\/ndt\/gfab232","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang Y, Hemmelder MH, Bos WJW, Snoep JD, de Vries APJ, Dekker FW, et al. Mapping health-related quality of life after kidney transplantation by group comparisons: a systematic review. Nephrol Dial Transpl. 2021;36(12):2327\u201339.","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"7030_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/ijc.24439","volume":"125","author":"CM Vajdic","year":"2009","unstructured":"Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125(8):1747\u201354.","journal-title":"Int J Cancer"},{"issue":"2","key":"7030_CR5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","volume":"49","author":"P Piselli","year":"2013","unstructured":"Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, et al. Risk of de Novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997\u20132009. Eur J Cancer. 2013;49(2):336\u201344.","journal-title":"Eur J Cancer"},{"issue":"3","key":"7030_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","volume":"14","author":"M Mohme","year":"2017","unstructured":"Mohme M, Riethdorf S, Pantel K. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat Rev Clin Oncol. 2017;14(3):155\u201367.","journal-title":"Nat Rev Clin Oncol"},{"issue":"19\u201320","key":"7030_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/gad.314617.118","volume":"32","author":"H Gonzalez","year":"2018","unstructured":"Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32(19\u201320):1267\u201384.","journal-title":"Genes Dev"},{"issue":"12","key":"7030_CR8","doi-asserted-by":"publisher","first-page":"1598168","DOI":"10.3389\/fmed.2025.1598168","volume":"17","author":"B Pellegrini","year":"2025","unstructured":"Pellegrini B, Leone F, Greco R, Maggiolini M, Provenzano M, Zaza G. Endocrine malignancies: a still neglected issue in kidney transplantation. Front Med (Lausanne). 2025;17(12):1598168.","journal-title":"Front Med (Lausanne)"},{"key":"7030_CR9","doi-asserted-by":"publisher","first-page":"1017498","DOI":"10.3389\/fonc.2022.1017498","volume":"12","author":"X Hao","year":"2022","unstructured":"Hao X, Lai W, Xia X, Xu J, Wu Y, Lv C, et al. Skin cancer outcomes and risk factors in renal transplant recipients: analysis of organ procurement and transplantation network data from 2000 to 2021. Front Oncol. 2022;12:1017498.","journal-title":"Front Oncol"},{"issue":"17","key":"7030_CR10","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","volume":"33","author":"MA Postow","year":"2015","unstructured":"Postow MA, Callahan MK, Wolchok JD. Immune checkpoint Blockade in cancer therapy. J Clin Oncol. 2015;33(17):1974\u201382.","journal-title":"J Clin Oncol"},{"issue":"2","key":"7030_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/cei.13081","volume":"191","author":"RAM Wilson","year":"2018","unstructured":"Wilson RAM, Evans TRJ, Fraser AR, Nibbs RJB. Immune checkpoint inhibitors: new strategies to checkmate cancer. Clin Exp Immunol. 2018;191(2):133\u201348.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"7030_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","volume":"6","author":"J Gong","year":"2018","unstructured":"Gong J, Chehrazi-Raffle A, Reddi S, Salgia R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018;6(1):8.","journal-title":"J Immunother Cancer"},{"issue":"17","key":"7030_CR13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373(17):1627\u201339.","journal-title":"N Engl J Med"},{"issue":"2","key":"7030_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ekir.2019.11.015","volume":"5","author":"S Manohar","year":"2019","unstructured":"Manohar S, Thongprayoon C, Cheungpasitporn W, Markovic SN, Herrmann SM. Systematic review of the safety of immune checkpoint inhibitors among kidney transplant patients. Kidney Int Rep. 2019;5(2):149\u201358.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"7030_CR15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/ijms22041741","volume":"22","author":"M Bocchetti","year":"2021","unstructured":"Bocchetti M, Scrima M, Melisi F, Luce A, Sperlongano R, Caraglia M, et al. LncRNAs and immunity: coding the immune system with noncoding oligonucleotides. Int J Mol Sci. 2021;22(4):1741.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7030_CR16","doi-asserted-by":"publisher","first-page":"102140","DOI":"10.1016\/j.omtn.2024.102140","volume":"35","author":"AM Cossu","year":"2024","unstructured":"Cossu AM, Melisi F, Noviello TMR, Pasquale LS, Grisolia P, Reale C, et al. MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer. Mol Ther Nucleic Acids. 2024;35(1):102140.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"7030_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/genes14071375","volume":"14","author":"A Chakrabortty","year":"2023","unstructured":"Chakrabortty A, Patton DJ, Smith BF, Agarwal P. MiRNAs: potential as biomarkers and therapeutic targets for cancer. Genes (Basel). 2023;14(7):1375.","journal-title":"Genes (Basel)"},{"issue":"4","key":"7030_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/gcc.22725","volume":"58","author":"MA Cortez","year":"2019","unstructured":"Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, et al. Role of MiRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer. 2019;58(4):244\u201353.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"7030_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38(3):276\u20138.","journal-title":"Nat Biotechnol"},{"key":"7030_CR20","first-page":"1438","volume":"5","author":"Y Chen","year":"2016","unstructured":"Chen Y, Lun AT, Smyth GK. From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edger quasi-likelihood pipeline. F1000Res. 2016;5:1438.","journal-title":"F1000Res"},{"issue":"10","key":"7030_CR21","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40(10):4288\u201397.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"7030_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"17","key":"7030_CR23","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, et al. The MultiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42(17):e133.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"7030_CR24","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"S Sherman","year":"2022","unstructured":"Sherman S, Hao BT, Qiu M, Jiao J, Baseler X, Lane MW. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"7030_CR25","doi-asserted-by":"crossref","unstructured":"Kuhn M. Building predictive models in R using the caret package. J Stat Softw. 2008; 28, 1\u201326.","DOI":"10.18637\/jss.v028.i05"},{"issue":"20","key":"7030_CR26","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21(20):3940\u20131.","journal-title":"Bioinformatics"},{"issue":"1","key":"7030_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"YOUDEN WJ","year":"1950","unstructured":"YOUDEN WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135.","journal-title":"Cancer"},{"issue":"1","key":"7030_CR28","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.4081\/rt.2017.6550","volume":"9","author":"P Dhakal","year":"2017","unstructured":"Dhakal P, Giri S, Siwakoti K, Rayamajhi S, Bhatt VR. Renal cancer in recipients of kidney transplant. Rare Tumors. 2017;9(1):6550.","journal-title":"Rare Tumors"},{"issue":"31","key":"7030_CR29","doi-asserted-by":"publisher","first-page":"50766","DOI":"10.18632\/oncotarget.9391","volume":"7","author":"W Zhiyu","year":"2016","unstructured":"Zhiyu W, Wang N, Wang Q, Peng C, Zhang J, Liu P, et al. The inflammasome: an emerging therapeutic oncotarget for cancer prevention. Oncotarget. 2016;7(31):50766\u201380.","journal-title":"Oncotarget"},{"issue":"1","key":"7030_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ndt\/gfy206","volume":"34","author":"P Pontrelli","year":"2019","unstructured":"Pontrelli P, Rascio F, Zaza G, Accetturo M, Simone S, Infante B, et al. Interleukin-27 is a potential marker for the onset of post-transplant malignancies. Nephrol Dial Transpl. 2019;34(1):157\u201366.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"7030_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/eji.201545456","volume":"45","author":"F McAllister","year":"2015","unstructured":"McAllister F, Kolls JK. Th17 cytokines in non-melanoma skin cancer. Eur J Immunol. 2015;45(3):692\u20134.","journal-title":"Eur J Immunol"},{"issue":"6","key":"7030_CR32","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/ki.2013.494","volume":"85","author":"G Wong","year":"2014","unstructured":"Wong G, Chapman JR, Craig JC. Death from cancer: a sobering truth for patients with kidney transplants. Kidney Int. 2014;85(6):1262\u20134.","journal-title":"Kidney Int"},{"issue":"1","key":"7030_CR33","doi-asserted-by":"publisher","first-page":"e14841","DOI":"10.1111\/ctr.14841","volume":"37","author":"A Coupier","year":"2023","unstructured":"Coupier A, Gallien Y, Boillot O, Walter T, Guillaud O, Vallin M, et al. Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: squaring the circle? Clin Transpl. 2023;37(1):e14841.","journal-title":"Clin Transpl"},{"issue":"2","key":"7030_CR34","first-page":"336","volume":"7","author":"Y Yildirim","year":"2006","unstructured":"Yildirim Y, Ozyilkan O, Emiroglu R, Demirhan B, Karakayali H, Haberal M. Early diagnosis of cancer in renal transplant patients: a single center experience. Asian Pac J Cancer Prev. 2006;7(2):336\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"7030_CR35","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1097\/TP.0000000000003215","volume":"104","author":"SJ Tingle","year":"2020","unstructured":"Tingle SJ, Sewpaul A, Bates L, Thompson ER, Shuttleworth V, Figueiredo R, et al. Dual MicroRNA Blockade increases expression of antioxidant protective proteins: implications for ischemia-reperfusion injury. Transplantation. 2020;104(9):1853\u201361.","journal-title":"Transplantation"},{"issue":"1","key":"7030_CR36","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1515\/biol-2021-0127","volume":"16","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zuo X. miR-25-3p protects renal tubular epithelial cells from apoptosis induced by renal IRI by targeting DKK3. Open Life Sci. 2021;16(1):1393\u2013404.","journal-title":"Open Life Sci"},{"issue":"1","key":"7030_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajt.2022.09.003","volume":"23","author":"L Shi","year":"2023","unstructured":"Shi L, Song Z, Li Y, Huang J, Zhao F, Luo Y, et al. MiR-20a-5p alleviates kidney ischemia\/reperfusion injury by targeting ACSL4-dependent ferroptosis. Am J Transpl. 2023;23(1):11\u201325.","journal-title":"Am J Transpl"},{"key":"7030_CR38","doi-asserted-by":"publisher","first-page":"104718","DOI":"10.1016\/j.phrs.2020.104718","volume":"155","author":"XR Zhao","year":"2020","unstructured":"Zhao XR, Zhang Z, Gao M, Li L, Sun PY, Xu LN, et al. MicroRNA-27a-3p aggravates renal ischemia\/reperfusion injury by promoting oxidative stress via targeting growth factor receptor-bound protein 2. Pharmacol Res. 2020;155:104718.","journal-title":"Pharmacol Res"},{"key":"7030_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2016.11.016","volume":"95","author":"M Ulbing","year":"2017","unstructured":"Ulbing M, Kirsch AH, Leber B, Lemesch S, M\u00fcnzker J, Schweighofer N, et al. MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation. Bone. 2017;95:115\u201323.","journal-title":"Bone"},{"issue":"6","key":"7030_CR40","first-page":"624","volume":"19","author":"A Abbasi","year":"2020","unstructured":"Abbasi A, Ebadi P, Yaghobi R, Karimi MH. Association of MicroRNA146a G\u2009>\u2009C and MicroRNA196a-2 C\u2009>\u2009T gene polymorphisms with outcome of kidney transplantation in Iranian patients. Iran J Allergy Asthma Immunol. 2020;19(6):624\u201331.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"7030_CR41","doi-asserted-by":"publisher","unstructured":"Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, H\u00f6flich H et al. Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2018;8(1):6003. https:\/\/doi.org\/10.1038\/s41598-018-23760-1.]. Sci Rep. 2017;7(1):14554.","DOI":"10.1038\/s41598-018-23760-1.]"},{"issue":"9","key":"7030_CR42","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/ajt.17097","volume":"22","author":"R Franzin","year":"2022","unstructured":"Franzin R, Stasi A, Sallustio F, Bruno S, Merlotti G, Quaglia M, et al. Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cells. Am J Transpl. 2022;22(9):2139\u201357.","journal-title":"Am J Transpl"},{"issue":"7","key":"7030_CR43","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1097\/TXD.0000000000000699","volume":"3","author":"R Bijkerk","year":"2017","unstructured":"Bijkerk R, Florijn BW, Khairoun M, Duijs JMGJ, Ocak G, de Vries APJ, et al. Acute rejection after kidney transplantation associates with Circulating MicroRNAs and vascular injury. Transpl Direct. 2017;3(7):e174.","journal-title":"Transpl Direct"},{"issue":"16","key":"7030_CR44","doi-asserted-by":"publisher","first-page":"11857","DOI":"10.18632\/aging.206049","volume":"16","author":"L Cong","year":"2024","unstructured":"Cong L, Zhao L, Shi Y, Bai Y, Guo Z. Circ_0006476 modulates macrophage apoptosis through the miR-3074-5p\/DLL4 axis: implications for Notch signalling pathway regulation in cardiovascular disease. Aging. 2024;16(16):11857\u201376.","journal-title":"Aging"},{"key":"7030_CR45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1166\/jbt.2020.2291","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Liu Y, Zhang Y, Hong Z. miR-425-5p inhibits rat mesangial cells (MCs) proliferation by targeting transforming growth factor beta (TGF-\u03b2)\/RelA (p65) under the condition of sitagliptin. J Biomaterials Tissue Eng. 2020;10:545\u201353.","journal-title":"J Biomaterials Tissue Eng"},{"key":"7030_CR46","doi-asserted-by":"crossref","unstructured":"Kumari M, Mohan A, Ecelbarger CM, Gupta A, Prasad N, Tiwari S. miR-451 loaded exosomes are released by the renal cells in response to injury and associated with reduced kidney function in human. Front Physiol. 2020;11:234.","DOI":"10.3389\/fphys.2020.00234"},{"issue":"1","key":"7030_CR47","first-page":"94","volume":"40","author":"S Saejong","year":"2022","unstructured":"Saejong S, Townamchai S, Somparn N, Tangtanatakul P, Ondee P, Hirankarn T. MicroRNA-21 in plasma exosome, but not from whole plasma, as a biomarker for the severe interstitial fibrosis and tubular atrophy (IF\/TA) in post-renal transplantation. Asian Pac J Allergy Immunol. 2022;40(1):94\u2013102.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"7030_CR48","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2215\/CJN.08020718","volume":"14","author":"KJ Ledeganck","year":"2019","unstructured":"Ledeganck KJ, Gielis EM, Abramowicz D, Stenvinkel P, Shiels PG, Van Craenenbroeck AH. MicroRNAs in AKI and kidney transplantation. Clin J Am Soc Nephrol. 2019;14(3):454\u201368.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"7030_CR49","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41598-019-40747-8","volume":"9","author":"H Sonoda","year":"2019","unstructured":"Sonoda H, Lee BR, Park KH, et al. MiRNA profiling of urinary exosomes to assess the progression of acute kidney injury. Sci Rep. 2019;9(1):4692.","journal-title":"Sci Rep"},{"issue":"3","key":"7030_CR50","doi-asserted-by":"publisher","first-page":"e0173292","DOI":"10.1371\/journal.pone.0173292","volume":"12","author":"QM Ge","year":"2017","unstructured":"Ge QM, Huang CM, Zhu XY, Bian F, Pan SM. Differentially expressed MiRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways. PLoS ONE. 2017;12(3):e0173292.","journal-title":"PLoS ONE"},{"issue":"6","key":"7030_CR51","doi-asserted-by":"publisher","first-page":"BSR20200527","DOI":"10.1042\/BSR20200527","volume":"40","author":"X Wang","year":"2020","unstructured":"Wang X, Wang Y, Kong M, Yang J. MiR-22-3p suppresses sepsis-induced acute kidney injury by targeting PTEN. Biosci Rep. 2020;40(6):BSR20200527.","journal-title":"Biosci Rep"},{"issue":"7","key":"7030_CR52","doi-asserted-by":"publisher","first-page":"e0253522","DOI":"10.1371\/journal.pone.0253522","volume":"16","author":"H Liu","year":"2021","unstructured":"Liu H, Chen C, Zeng J, Zhao Z, Hu Q. MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells. PLoS ONE. 2021;16(7):e0253522.","journal-title":"PLoS ONE"},{"issue":"1","key":"7030_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-017-0688-6","volume":"16","author":"D Ren","year":"2017","unstructured":"Ren D, Yang Q, Dai Y, Guo W, Du H, Song L, et al. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-\u03baB signaling pathway. Mol Cancer. 2017;16(1):117.","journal-title":"Mol Cancer"},{"issue":"14","key":"7030_CR54","doi-asserted-by":"publisher","first-page":"12682","DOI":"10.18632\/oncotarget.3707","volume":"6","author":"RM Burnett","year":"2015","unstructured":"Burnett RM, Craven KE, Krishnamurthy P, Goswami CP, Badve S, Crooks P, et al. Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells. Oncotarget. 2015;6(14):12682\u201396.","journal-title":"Oncotarget"},{"issue":"1","key":"7030_CR55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm1519","volume":"13","author":"BK Park","year":"2007","unstructured":"Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 2007;13(1):62\u20139.","journal-title":"Nat Med"},{"issue":"41","key":"7030_CR56","doi-asserted-by":"publisher","first-page":"69551","DOI":"10.18632\/oncotarget.18449","volume":"8","author":"V Petrozza","year":"2017","unstructured":"Petrozza V, Pastore AL, Palleschi G, Tito C, Porta N, Ricci S, et al. Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma. Oncotarget. 2017;8(41):69551\u20138.","journal-title":"Oncotarget"},{"issue":"4","key":"7030_CR57","doi-asserted-by":"publisher","first-page":"e3320","DOI":"10.1002\/jgm.3320","volume":"23","author":"Z Nashtahosseini","year":"2021","unstructured":"Nashtahosseini Z, Aghamaali MR, Sadeghi F, Heydari N, Parsian H. Circulating status of MicroRNAs 660-5p and 210-3p in breast cancer patients. J Gene Med. 2021;23(4):e3320.","journal-title":"J Gene Med"},{"key":"7030_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12041-021-01265-7","volume":"100","author":"M Maryam","year":"2021","unstructured":"Maryam M, Naemi M, Hasani SS. A comprehensive review on oncogenic MiRNAs in breast cancer. J Genet. 2021;100:15.","journal-title":"J Genet"},{"key":"7030_CR59","doi-asserted-by":"publisher","first-page":"634596","DOI":"10.3389\/fonc.2021.634596","volume":"11","author":"G Du","year":"2021","unstructured":"Du G, Yu X, Chen Y, Cai W. MiR-1-3p suppresses colorectal cancer cell proliferation and metastasis by inhibiting YWHAZ-Mediated Epithelial-Mesenchymal transition. Front Oncol. 2021;11:634596.","journal-title":"Front Oncol"},{"key":"7030_CR60","doi-asserted-by":"publisher","first-page":"6529255","DOI":"10.1155\/2021\/6529255","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu M, Jin H, Peng B, Dai L, Wang S, et al. Synthetic evaluation of MicroRNA-1-3p expression in head and neck squamous cell carcinoma based on microarray chips and MicroRNA sequencing. Biomed Res Int. 2021;2021:6529255.","journal-title":"Biomed Res Int"},{"issue":"1","key":"7030_CR61","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12876-022-02203-2","volume":"22","author":"S Zhou","year":"2022","unstructured":"Zhou S, Han H, Yang L, Lin H. MiR-1-3p targets CENPF to repress tumor-relevant functions of gastric cancer cells. BMC Gastroenterol. 2022;22(1):145.","journal-title":"BMC Gastroenterol"},{"key":"7030_CR62","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fonc.2019.00120","volume":"9","author":"T Li","year":"2019","unstructured":"Li T, Wang X, Jing L, Li Y. MiR-1-3p inhibits lung adenocarcinoma cell tumorigenesis via targeting protein regulator of cytokinesis 1. Front Oncol. 2019;9:120.","journal-title":"Front Oncol"},{"issue":"1","key":"7030_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13046-018-0895-z","volume":"37","author":"SM Li","year":"2018","unstructured":"Li SM, Wu HL, Yu X, Tang K, Wang SG, Ye ZQ, Hu J. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1. J Exp Clin Cancer Res. 2018;37(1):219.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"7030_CR64","doi-asserted-by":"publisher","first-page":"646","DOI":"10.21037\/tau.2019.12.10","volume":"9","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhou J, Wu X, Huang J, Chen W, Liu D, et al. miR-30a-3p inhibits renal cancer cell invasion and metastasis through targeting ATG12. Transl Androl Urol. 2020;9(2):646\u201353.","journal-title":"Transl Androl Urol"},{"issue":"18","key":"7030_CR65","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.3390\/ijms21186459","volume":"21","author":"H Shimomura","year":"2020","unstructured":"Shimomura H, Okada R, Tanaka T, Hozaka Y, Wada M, Moriya S, et al. Role of miR-30a-3p regulation of oncogenic targets in pancreatic ductal adenocarcinoma pathogenesis. Int J Mol Sci. 2020;21(18):6459.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"7030_CR66","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41419-022-04889-4","volume":"13","author":"TI Hwang","year":"2022","unstructured":"Hwang TI, Chen PC, Tsai TF, Lin JF, Chou KY, Ho CY, et al. Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion [published correction appears in. Cell Death Dis. 2022;13(5):514.","journal-title":"Cell Death Dis"},{"issue":"11","key":"7030_CR67","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.ejso.2013.11.008","volume":"40","author":"W Wang","year":"2014","unstructured":"Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, et al. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Eur J Surg Oncol. 2014;40(11):1586\u201394.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"7030_CR68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/1878-0261.13339","volume":"17","author":"K Tanigawa","year":"2023","unstructured":"Tanigawa K, Misono S, Mizuno K, Asai S, Suetsugu T, Uchida A, et al. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control. Mol Oncol. 2023;17(2):328\u201343.","journal-title":"Mol Oncol"},{"issue":"9","key":"7030_CR69","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/cancers10090315","volume":"10","author":"G Gonzalez Dos Anjos","year":"2018","unstructured":"Gonzalez Dos Anjos G, de Almeida L, Gomes de Almeida BC, Mour\u00e3o T, Lavorato Rocha A, De Nardo Maffazioli G, et al. Could MiRNA signatures be useful for predicting uterine sarcoma and carcinosarcoma prognosis and treatment? Cancers (Basel). 2018;10(9):315.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"7030_CR70","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3892\/or.2023.8523","volume":"49","author":"K Yoshida","year":"2023","unstructured":"Yoshida K, Yokoi A, Kitagawa M, Sugiyama M, Yamamoto T, Nakayama J, et al. Downregulation of miR\u201310b\u20135p facilitates the proliferation of uterine leiomyosarcoma cells: A MicroRNA sequencing\u2013based approach. Oncol Rep. 2023;49(5):86.","journal-title":"Oncol Rep"},{"issue":"3","key":"7030_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1620\/tjem.2023.J028","volume":"260","author":"D Du","year":"2023","unstructured":"Du D, Chen W, Wei D, Yu K, Gan D, Xu Z. MiR-10b-5p impairs TET2-Mediated Inhibition of PD-L1 transcription thus promoting immune evasion and tumor progression in glioblastoma. Tohoku J Exp Med. 2023;260(3):205\u201314.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"7030_CR72","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/jcm9010281","volume":"9","author":"HJ Cho","year":"2020","unstructured":"Cho HJ, Eun JW, Baek GO, Seo CW, Ahn HR, Kim SS, et al. Serum Exosomal microrna, miR-10b-5p, as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. J Clin Med. 2020;9(1):281.","journal-title":"J Clin Med"},{"issue":"1","key":"7030_CR73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12094-023-03209-2","volume":"26","author":"S Ghafouri-Fard","year":"2024","unstructured":"Ghafouri-Fard S, Askari A, Hussen BM, Taheri M, Akbari Dilmaghani N. Role of miR-424 in the carcinogenesis. Clin Transl Oncol. 2024;26(1):16\u201338.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"7030_CR74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12890-024-02887-0","volume":"24","author":"J Wu","year":"2024","unstructured":"Wu J, Fu G, Luo C, Chen L, Liu Q. Cuproptosis-related CeRNA axis triggers cell proliferation and cell cycle through CBX2 in lung adenocarcinoma. BMC Pulm Med. 2024;24(1):85.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"7030_CR75","first-page":"9126","volume":"15","author":"L Wu","year":"2018","unstructured":"Wu L, Yang F, Lin B, Chen X, Yin S, Zhang F, et al. MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation. Oncol Lett. 2018;15(6):9126\u201332.","journal-title":"Oncol Lett"},{"issue":"21","key":"7030_CR76","first-page":"7233","volume":"22","author":"JT Wang","year":"2018","unstructured":"Wang JT, Wang ZH. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2018;22(21):7233\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"7030_CR77","doi-asserted-by":"publisher","first-page":"e0239386","DOI":"10.1371\/journal.pone.0239386","volume":"15","author":"SH Loosen","year":"2020","unstructured":"Loosen SH, Wirtz TH, Roy S, Vucur M, Castoldi M, Schneider AT, et al. Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma. PLoS ONE. 2020;15(9):e0239386.","journal-title":"PLoS ONE"},{"issue":"4","key":"7030_CR78","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41416-023-02532-3","volume":"130","author":"H Kamiya","year":"2024","unstructured":"Kamiya H, Komatsu S, Takashima Y, Ishida R, Arakawa H, Nishibeppu K, et al. Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. Br J Cancer. 2024;130(4):671\u201381.","journal-title":"Br J Cancer"},{"issue":"9","key":"7030_CR79","doi-asserted-by":"publisher","first-page":"e669","DOI":"10.1002\/mco2.669","volume":"5","author":"X Liu","year":"2024","unstructured":"Liu X, Shen J, Yan H, Hu J, Liao G, Liu D, et al. Posttransplant complications: molecular mechanismsand therapeutic interventions. MedComm. 2024;5(9):e669.","journal-title":"MedComm"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07030-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T13:03:37Z","timestamp":1759496617000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07030-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7030"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07030-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the Declaration of Helsinki and was approved by all local Ethics Committees of the participating centers (Approval nr 0029851\/I \u2212\u20092023 by the Ethical Committee of the Coordinating Centre at University of Campania \u201cLuigi Vanvitelli\u201d).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1053"}}